ONCT Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 8.00%

Insider Buying (Last 12 Months): $102,565.84

Insider Selling (Last 12 Months): $0.00

Oncternal Therapeutics Insider Trading History Chart

Oncternal Therapeutics Share Price & Price History

^$8.29

▲ +0.04 (0.48%)

As of 04/26/2024 01:00 AM ET

Days: 30 | 90 | 365

Better than Bitcoin? The Biotech Stock with 46,751% Potential

From Behind the Markets | Ad

4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.

Get the name of the stock here >>>

Oncternal Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/8/2024	Robert James Wills	Director	Buy	3,086	$8.96	$27,650.56	10,000
3/28/2024	Robert James Wills	Director	Buy	6,914	$8.48	$58,630.72	6,914
2/23/2024	David F. Hale	Director	Buy	714	$9.04	$6,454.56	714
6/14/2023	Gunnar F Kaufmann	Insider	Buy	150	$7.20	$1,080.00	4,736
6/12/2023	Gunnar F Kaufmann	Insider	Buy	1,250	$7.00	$8,750.00	4,586
4/14/2023	Salim Yazji	Insider	Buy	250	$6.00	$1,500.00	8,233
4/13/2023	James B. Breitmeyer	CEO	Buy	5,000	$5.80	$29,000.00	7,327
4/13/2023	Richard G Vincent	CFO	Buy	1,500	$6.00	$9,000.00	7,842
4/12/2023	Chase C Leavitt	General Counsel	Buy	750	$5.80	$4,350.00	4,845
4/12/2023	Salim Yazji	Insider	Buy	500	$5.60	$2,800.00	7,483
3/28/2022	Richard G Vincent	CFO	Buy	125	$28.00	$3,500.00
3/24/2022	Richard G Vincent	CFO	Buy	0	$29.00	$0.00
1/27/2022	Chase C Leavitt	General Counsel	Buy	425	$35.60	$15,130.00
1/27/2022	James B. Breitmeyer	CEO	Buy	1,250	$33.60	$42,000.00
1/27/2022	Richard G Vincent	CFO	Buy	500	$35.00	$17,500.00
6/30/2021	David F. Hale	Director	Sell	183	$95.00	$17,385.00
6/11/2021	Chase C. Leavitt	General Counsel	Buy	75	$109.00	$8,175.00	75

Better than Bitcoin? The Biotech Stock with 46,751% Potential

From Behind the Markets | Ad

4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.

Get the name of the stock here >>>

SEC Filings (Institutional Ownership Changes) for Oncternal Therapeutics (NASDAQ:ONCT)

16.05% of Oncternal Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Oncternal Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
1/11/2024	Pasadena Private Wealth LLC	500,000	$0.27M	0.1%	+79.4%	16.961%
11/3/2023	Richmond Brothers Inc.	494,042	$0.15M	0.3%	+69.8%	0.838%
10/11/2023	Pasadena Private Wealth LLC	278,750	$84K	0.0%	N/A	0.473%
8/11/2023	Richmond Brothers Inc.	291,032	$100K	0.2%	+658.6%	0.496%
8/7/2023	Acadian Asset Management LLC	107,967	$36K	0.0%	-34.8%	0.184%
5/10/2023	Richmond Brothers Inc.	38,362	$30K	0.1%	N/A	0.065%
1/23/2023	Waypoint Capital Advisors LLC	38,269	$38K	0.0%	N/A	0.068%
11/14/2022	Ergoteles LLC	100,600	$90K	0.0%	-52.8%	0.179%
8/17/2022	Quantum Private Wealth LLC	455,656	$0.51M	0.3%	+2.4%	0.856%
8/8/2022	Resources Investment Advisors LLC.	40,448	$45K	0.0%	+33.7%	0.082%
8/5/2022	Regents of The University of California	53,554	$59K	0.0%	N/A	0.108%
7/27/2022	Bailard Inc.	84,200	$93K	0.0%	N/A	0.170%
5/12/2022	Beta Wealth Group Inc.	32,000	$44K	0.0%	N/A	0.065%
5/11/2022	ACT Capital Management LLC	225,000	$0.31M	0.3%	-37.5%	0.455%
5/11/2022	GSA Capital Partners LLP	71,247	$99K	0.0%	+519.5%	0.144%
4/26/2022	Ieq Capital LLC	144,434	$0.20M	0.0%	+100.0%	0.292%
4/19/2022	Waypoint Capital Advisors LLC	44,375	$52K	0.0%	N/A	0.090%
2/23/2022	Resources Investment Advisors LLC.	21,480	$49K	0.0%	+52.0%	0.043%
2/14/2022	IPG Investment Advisors LLC	23,691	$54K	0.0%	-23.0%	0.048%
2/14/2022	GSA Capital Partners LLP	11,500	$26K	0.0%	N/A	0.023%
2/9/2022	Principal Financial Group Inc.	48,218	$0.11M	0.0%	-43.0%	0.098%
2/8/2022	Northern Trust Corp	396,576	$0.90M	0.0%	-30.3%	0.802%
2/7/2022	SG Americas Securities LLC	11,890	$27K	0.0%	-55.3%	0.024%
2/3/2022	Advisor Group Holdings Inc.	21,831	$50K	0.0%	-22.3%	0.044%
2/3/2022	Total Clarity Wealth Management Inc.	20,056	$46K	0.0%	-24.1%	0.041%
1/28/2022	Allspring Global Investments Holdings LLC	141,216	$0.32M	0.0%	N/A	0.286%
1/19/2022	Traverso Chambers Private Wealth Management LLC	12,000	$27K	0.0%	N/A	0.024%
1/7/2022	Vigilare Wealth Management	49,325	$0.11M	0.1%	-22.3%	0.100%
11/16/2021	Two Sigma Advisers LP	124,600	$0.52M	0.0%	+112.3%	0.252%
11/16/2021	Two Sigma Investments LP	452,471	$1.89M	0.0%	-18.1%	0.915%
11/16/2021	United Capital Financial Advisers LLC	113,410	$0.47M	0.0%	+2.5%	0.229%
11/15/2021	HighVista Strategies LLC	23,121	$97K	0.1%	N/A	0.047%
11/12/2021	Renaissance Technologies LLC	142,805	$0.60M	0.0%	+173.6%	0.289%
11/12/2021	Parkman Healthcare Partners LLC	325,384	$1.36M	0.3%	-21.7%	0.658%
11/12/2021	Geode Capital Management LLC	762,449	$3.18M	0.0%	+3.1%	1.543%
11/10/2021	Mercer Global Advisors Inc. ADV	50,143	$0.21M	0.0%	-49.9%	0.102%
11/10/2021	Goldman Sachs Group Inc.	103,978	$0.43M	0.0%	+371.4%	0.211%
11/10/2021	Creative Planning	44,036	$0.18M	0.0%	+90.6%	0.089%
11/9/2021	Barclays PLC	21,713	$91K	0.0%	-54.7%	0.044%
11/8/2021	State Board of Administration of Florida Retirement System	38,662	$0.16M	0.0%	N/A	0.078%
11/5/2021	Resources Investment Advisors LLC.	14,135	$59K	0.0%	N/A	0.029%
11/5/2021	Advisor Group Holdings Inc.	28,081	$0.12M	0.0%	+10.3%	0.057%
11/4/2021	Deutsche Bank AG	25,460	$0.11M	0.0%	-61.6%	0.052%
11/2/2021	New York State Common Retirement Fund	15,749	$66K	0.0%	-58.4%	0.032%
11/1/2021	SG Americas Securities LLC	26,617	$0.11M	0.0%	+74.4%	0.054%
10/21/2021	Total Clarity Wealth Management Inc.	26,430	$0.11M	0.1%	N/A	0.054%
10/19/2021	Vigilare Wealth Management	63,460	$0.27M	0.2%	+20.8%	0.129%
8/18/2021	Ikarian Capital LLC	200,204	$0.95M	0.1%	-56.5%	0.405%
8/17/2021	Millennium Management LLC	154,165	$0.73M	0.0%	-61.0%	0.312%
8/17/2021	Apis Capital Advisors LLC	120,000	$0.57M	0.5%	-16.7%	0.243%
8/17/2021	Boothbay Fund Management LLC	20,928	$99K	0.0%	-56.5%	0.042%
8/16/2021	Cubist Systematic Strategies LLC	20,300	$96K	0.0%	-47.7%	0.041%
8/16/2021	California State Teachers Retirement System	61,110	$0.29M	0.0%	N/A	0.124%
8/16/2021	Occudo Quantitative Strategies LP	15,996	$76K	0.0%	+38.2%	0.032%
8/16/2021	Schonfeld Strategic Advisors LLC	16,251	$77K	0.0%	-83.9%	0.033%
8/16/2021	Charles Schwab Investment Management Inc.	109,677	$0.52M	0.0%	+591.8%	0.222%
8/16/2021	State Street Corp	731,191	$3.47M	0.0%	+3,685.8%	1.481%
8/16/2021	Nuveen Asset Management LLC	206,298	$0.98M	0.0%	N/A	0.418%
8/16/2021	Goldman Sachs Group Inc.	22,055	$0.11M	0.0%	-79.6%	0.045%
8/13/2021	Renaissance Technologies LLC	52,200	$0.25M	0.0%	N/A	0.106%
8/13/2021	Northern Trust Corp	589,645	$2.80M	0.0%	+598.1%	1.194%
8/13/2021	Altium Capital Management LP	172,218	$0.82M	0.2%	-2.3%	0.349%
8/13/2021	OLD Mission Capital LLC	58,535	$0.28M	0.0%	N/A	0.119%
8/13/2021	Jump Financial LLC	58,225	$0.28M	0.0%	N/A	0.118%
8/13/2021	Qube Research & Technologies Ltd	74,253	$0.35M	0.0%	N/A	0.150%
8/13/2021	Geode Capital Management LLC	739,399	$3.51M	0.0%	+103.2%	1.497%
8/13/2021	Vanguard Group Inc.	2,107,600	$10.01M	0.0%	+19.6%	4.268%
8/13/2021	ProShare Advisors LLC	11,481	$55K	0.0%	N/A	0.023%
8/12/2021	SG Americas Securities LLC	15,266	$73K	0.0%	N/A	0.031%
8/12/2021	JPMorgan Chase & Co.	16,991	$81K	0.0%	+6,950.2%	0.034%
8/12/2021	Bank of Montreal Can	178,456	$0.86M	0.0%	+39.7%	0.361%
8/11/2021	Bank of New York Mellon Corp	128,058	$0.61M	0.0%	+627.6%	0.259%
8/11/2021	BlackRock Inc.	3,199,729	$15.20M	0.0%	+197.5%	6.479%
8/11/2021	Deutsche Bank AG	66,379	$0.32M	0.0%	N/A	0.134%
8/10/2021	Principal Financial Group Inc.	86,746	$0.41M	0.0%	N/A	0.176%
8/5/2021	Rhumbline Advisers	53,893	$0.26M	0.0%	N/A	0.109%
8/5/2021	NinePointTwo Capital	10,342	$49K	0.0%	N/A	0.021%
8/4/2021	Creative Planning	23,099	$0.11M	0.0%	-66.8%	0.047%
8/2/2021	New York State Common Retirement Fund	37,900	$0.18M	0.0%	N/A	0.077%
8/2/2021	Advisor Group Holdings Inc.	25,450	$0.12M	0.0%	+248.6%	0.052%
7/31/2021	Vigilare Wealth Management	52,535	$0.25M	0.2%	+66.6%	0.106%
5/18/2021	Millennium Management LLC	395,304	$3.29M	0.0%	+24.7%	0.801%
5/18/2021	Cubist Systematic Strategies LLC	38,829	$0.32M	0.0%	N/A	0.079%
5/18/2021	Jane Street Group LLC	22,987	$0.19M	0.0%	N/A	0.047%
5/17/2021	Schonfeld Strategic Advisors LLC	101,200	$0.84M	0.0%	+42.9%	0.205%
5/17/2021	Ameriprise Financial Inc.	435,224	$3.62M	0.0%	N/A	0.882%
5/17/2021	HRT Financial LP	28,732	$0.24M	0.0%	N/A	0.058%
5/17/2021	Ikarian Capital LLC	460,323	$3.83M	0.1%	-55.3%	0.932%
5/17/2021	Goldman Sachs Group Inc.	108,096	$0.90M	0.0%	N/A	0.219%
5/14/2021	Aureus Asset Management LLC	30,211	$0.25M	0.0%	-57.0%	0.061%
5/14/2021	Occudo Quantitative Strategies LP	11,573	$96K	0.0%	N/A	0.023%
5/14/2021	Parkman Healthcare Partners LLC	778,785	$6.48M	1.5%	+106.7%	1.577%
5/13/2021	Sand Hill Global Advisors LLC	10,000	$83K	0.0%	N/A	0.020%
5/13/2021	Citigroup Inc.	8,090	$67K	0.0%	N/A	0.016%
5/13/2021	Bank of Montreal Can	127,742	$1.19M	0.0%	N/A	0.259%
5/12/2021	Northern Trust Corp	84,465	$0.70M	0.0%	+90.5%	0.171%
5/12/2021	Geode Capital Management LLC	363,916	$3.03M	0.0%	+153.6%	0.737%
5/12/2021	IPG Investment Advisors LLC	31,106	$0.26M	0.1%	N/A	0.063%
5/12/2021	UBS Group AG	3,287	$27K	0.0%	N/A	0.007%
5/11/2021	Mercer Global Advisors Inc. ADV	100,143	$0.83M	0.0%	N/A	0.203%

Data available starting January 2016

Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of oncology therapies for cancers with critical unmet medical needs. The company's clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to receptor-tyrosine kinase-like Orphan Receptor 1 (ROR1); and ONCT-216, a small molecule inhibiting the biological activity of ETS-family transcription factor oncoproteins, which is in Phase 1/2 clinical trial. It is also developing ONCT-808, a chimeric antigen receptor T-cells (CAR-T), which is in Phase 1/2 clinical trial for the treatment of hematologic malignancies and solid tumors, as well as targets ROR1; and ONCT-534, a dual-action androgen receptor inhibitor product candidate in preclinical development for the treatment of castration-resistant prostate and other androgen receptor-driven cancers. The company has license agreements with the Regents of the University of California; Georgetown University; The University of Texas MD Anderson Cancer Center; Shanghai Pharmaceutical (USA) Inc.; and University of Tennessee Research Foundation. Oncternal Therapeutics, Inc. is headquartered in San Diego, California.

Today's Range

Now: $8.29

$8.00

$8.29

50 Day Range

MA: $8.84

$7.80

$10.15

52 Week Range

Now: $8.29

$5.57

$13.14

Volume

1,441 shs

Average Volume

11,793 shs

Market Capitalization

$22.29 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.26

Who are the company insiders with the largest holdings of Oncternal Therapeutics?: Oncternal Therapeutics' top insider investors include:
Robert James Wills (Director)
Salim Yazji (Insider)
Richard G Vincent (CFO)
James B Breitmeyer (CEO)
Chase C Leavitt (General Counsel)
Gunnar F Kaufmann (Insider)
David F Hale (Director)
Learn More about top insider investors at Oncternal Therapeutics.